ZSTK474 targeting PIK3R3 inhibits the Wilms’ tumor through G0 / G1 phase arrest
This research provides insight into the potential of ZSTK474 and other PI3K inhibitors for treating nephroblastoma.
Authors
- Maoxian Li (ORCID: https://orcid.org/0000-0001-6158-065X)
- Chenghao Zhanghuang (ORCID: https://orcid.org/0000-0001-6421-767X)
- Liming Jin (ORCID: https://orcid.org/0000-0002-6695-7193)
- Jinkui Wang (ORCID: https://orcid.org/0000-0002-9719-0757)
- Xin Wu
- Mujie Li (ORCID: https://orcid.org/0000-0003-3140-6217)
- Tao Mi (ORCID: https://orcid.org/0000-0002-5244-1479)
- Zhang Wang (ORCID: https://orcid.org/0000-0001-5947-5092)
- Dawei He (ORCID: https://orcid.org/0000-0002-1695-5886)
- Zhaoying Wang (ORCID: https://orcid.org/0009-0000-7718-888X)
- Zhaoxia Zhang (ORCID: https://orcid.org/0009-0007-2226-9560)
- Jiayan Liu (ORCID: https://orcid.org/0000-0003-0843-0585)
Institutions
- University of Electronic Science and Technology of China (CN)
- Chengdu Women's and Children's Central Hospital (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1371/journal.pone.0312178
- Citations
- 1
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.23